Literature DB >> 30909834

Familial Cerebral Cavernous Malformations.

Atif Zafar1, Syed A Quadri2, Mudassir Farooqui1, Asad Ikram1, Myranda Robinson1, Blaine L Hart3, Marc C Mabray3, Catherine Vigil4, Alan T Tang5, Mark L Kahn5, Howard Yonas6, Michael T Lawton7, Helen Kim8, Leslie Morrison1.   

Abstract

Entities:  

Keywords:  brain; developmental venous anomalies; familial cerebral cavernous malformation; hemosiderin; mutation

Mesh：

Year:  2019        PMID： 30909834      PMCID： PMC6924279          DOI： 10.1161/STROKEAHA.118.022314

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  55 in total

1.  Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.

Authors:  Hélène Choquet; Jeffrey Nelson; Ludmila Pawlikowska; Charles E McCulloch; Amy Akers; Beth Baca; Yasir Khan; Blaine Hart; Leslie Morrison; Helen Kim
Journal:  Cerebrovasc Dis       Date:  2013-12-21       Impact factor: 2.762

2.  Corrigendum: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Authors:  Zinan Zhou; Alan T Tang; Weng-Yew Wong; Sharika Bamezai; Lauren M Goddard; Robert Shenkar; Su Zhou; Jisheng Yang; Alexander C Wright; Matthew Foley; J Simon C Arthur; Kevin J Whitehead; Issam A Awad; Dean Y Li; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2016-05-25       Impact factor: 49.962

3.  RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.

Authors:  Robert Shenkar; Changbin Shi; Cecilia Austin; Thomas Moore; Rhonda Lightle; Ying Cao; Lingjiao Zhang; Meijing Wu; Hussein A Zeineddine; Romuald Girard; David A McDonald; Autumn Rorrer; Carol Gallione; Peter Pytel; James K Liao; Douglas A Marchuk; Issam A Awad
Journal:  Stroke       Date:  2016-11-22       Impact factor: 7.914

4.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

5.  First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencing.

Authors:  Stefanie Spiegler; Matthias Rath; Sabine Hoffjan; Philipp Dammann; Ulrich Sure; Axel Pagenstecher; Tim Strom; Ute Felbor
Journal:  Neurogenetics       Date:  2017-12-02       Impact factor: 2.660

6.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

Review 7.  Management of cerebral cavernous malformations: from diagnosis to treatment.

Authors:  Nikolaos Mouchtouris; Nohra Chalouhi; Ameet Chitale; Robert M Starke; Stavropoula I Tjoumakaris; Robert H Rosenwasser; Pascal M Jabbour
Journal:  ScientificWorldJournal       Date:  2015-01-05

8.  Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.

Authors:  Margaret A Horne; Kelly D Flemming; I-Chang Su; Christian Stapf; Jin Pyeong Jeon; Da Li; Susanne S Maxwell; Philip White; Teresa J Christianson; Ronit Agid; Won-Sang Cho; Chang Wan Oh; Zhen Wu; Jun-Ting Zhang; Jeong Eun Kim; Karel Ter Brugge; Robert Willinsky; Robert D Brown; Gordon D Murray; Rustam Al-Shahi Salman
Journal:  Lancet Neurol       Date:  2015-12-02       Impact factor: 44.182

9.  Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.

Authors:  Alan T Tang; Jaesung P Choi; Jonathan J Kotzin; Yiqing Yang; Courtney C Hong; Nicholas Hobson; Romuald Girard; Hussein A Zeineddine; Rhonda Lightle; Thomas Moore; Ying Cao; Robert Shenkar; Mei Chen; Patricia Mericko; Jisheng Yang; Li Li; Ceylan Tanes; Dmytro Kobuley; Urmo Võsa; Kevin J Whitehead; Dean Y Li; Lude Franke; Blaine Hart; Markus Schwaninger; Jorge Henao-Mejia; Leslie Morrison; Helen Kim; Issam A Awad; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2017-05-10       Impact factor: 49.962

10.  Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Authors:  Zinan Zhou; Alan T Tang; Weng-Yew Wong; Sharika Bamezai; Lauren M Goddard; Robert Shenkar; Su Zhou; Jisheng Yang; Alexander C Wright; Matthew Foley; J Simon C Arthur; Kevin J Whitehead; Issam A Awad; Dean Y Li; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2016-03-30       Impact factor: 49.962
View more
  23 in total

Review 1.  Activated protein C in neuroprotection and malaria.

Authors:  Laurent O Mosnier
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

2.  Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial.

Authors:  Marc C Mabray; Arvind Caprihan; Jeffrey Nelson; Charles E McCulloch; Atif Zafar; Helen Kim; Blaine L Hart; Leslie Morrison
Journal:  Transl Stroke Res       Date:  2019-10-23       Impact factor: 6.829

3.  Identification of a novel LATS1 variant associated with familial cerebral cavernous malformations in a Chinese family.

Authors:  Liangyuan Geng; Tao Jiang; Yihao Zhu; Qingru Wang; Wenwen Yuan; Xinhua Hu; Yuanjie Zou; Hong Xiao; Hongyi Liu
Journal:  Neurol Sci       Date:  2022-08-19       Impact factor: 3.830

4.  Compendium of causative genes and their encoded proteins for common monogenic disorders.

Authors:  Tucker L Apgar; Charles R Sanders
Journal:  Protein Sci       Date:  2021-09-21       Impact factor: 6.993

5.  Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.

Authors:  Ana Filipa Geraldo; Cesar Augusto P F Alves; Aysha Luis; Domenico Tortora; Joana Guimarães; Daisy Abreu; Sofia Reimão; Marco Pavanello; Patrizia de Marco; Marcello Scala; Valeria Capra; Rui Vaz; Andrea Rossi; Erin Simon Schwartz; Kshitij Mankad; Mariasavina Severino
Journal:  Neuroradiology       Date:  2022-10-06       Impact factor: 2.995

6.  High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort.

Authors:  M C Mabray; J Starcevich; J Hallstrom; M Robinson; M Bartlett; J Nelson; A Zafar; H Kim; L Morrison; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

Review 7.  Precision Medicine Approaches to Vascular Disease: JACC Focus Seminar 2/5.

Authors:  Clint L Miller; Amy R Kontorovich; Ke Hao; Lijiang Ma; Conrad Iyegbe; Johan L M Björkegren; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2021-05-25       Impact factor: 24.094

8.  Asymptomatic Familial Multiple Cerebral Cavernous Malformation in a 73-Year-Old Woman.

Authors:  Klenam Dzefi-Tettey; Emmanuel Kobina Mesi Edzie; Philip Narteh Gorleku; Henry Kusodzi; Abdul Raman Asemah
Journal:  Case Rep Radiol       Date:  2021-05-21

9.  Monitoring and Prognostic Analysis of Severe Cerebrovascular Diseases Based on Multi-Scale Dynamic Brain Imaging.

Authors:  Suting Zhong; Kai Sun; Xiaobing Zuo; Aihong Chen
Journal:  Front Neurosci       Date:  2021-06-30       Impact factor: 4.677

Review 10.  The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology.

Authors:  Ljuba C Ponomarev; Jakub Ksiazkiewicz; Michael W Staring; Aernout Luttun; An Zwijsen
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.